Table S1.
Additional baseline demographics in the ITT population
| Variable | Cic dose
|
|||
|---|---|---|---|---|
| 160 μg/day (N=120) |
320 μg/day (N=122) |
640 μg/day (N=125) |
Total (N=367) |
|
| Race, n (%) | ||||
| Asian | 0 | 0 | 0 | 0 |
| Black | 6 (5.0) | 5 (4.1) | 4 (3.2) | 15 (4.1) |
| White | 113 (94.2) | 115 (94.3) | 114 (91.2) | 342 (93.2) |
| Other | 1 (0.8) | 2 (1.6) | 7 (5.6) | 10 (2.7) |
| BMI group, n (%) | ||||
| ≤30 kg/m2 | 84 (70.0) | 82 (67.2) | 92 (73.6) | 258 (70.3) |
| >30 kg/m2 | 36 (30.0) | 40 (32.8) | 33 (26.4) | 109 (29.7) |
| Pre-bronchodilator FEV1, L (SD) |
2.20 (0.79) | 2.35 (0.80) | 2.23 (0.80) | 2.26 (0.80) |
| Post-bronchodilator FEV1, L (SD) |
2.71 (0.92) | 2.84 (0.88) | 2.76 (0.91) | 2.77 (0.90) |
Abbreviations: BMI, body mass index; Cic, ciclesonide; FEV1, forced expiratory volume in 1 second; ITT, intention-to-treat; SD, standard deviation.